CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

Tag: RWE

Connect 2023

OXON’s at the Global Clinical Trials Connect 2023 Conference

Nawab Qizilbash will be speaking at the Global Clinical Trial Connect 2023 Conference 10- 11 May 2023 Nawab Qizilbash, Senior Clinical Epidemiologist and Head of OXON will be participating at the Global Clinical Trials Connect 2023 Conference on Wednesday, 10 May at 11:20h BST | 12:20h CEST. Under the title of “The complementary roles of…
Read more

Global Clinical Trials Connect 2022

OXON’s speaker at the Global Clinical Trials Connect 2022 conference

Nawab Qizilbash will be speaking at the Global Clinical Trial Connect 2022 Virtual Conference and Expo 21 – 22 September 2022 Nawab Qizilbash, Senior Clinical Epidemiologist and Head of OXON will be participating at the Global Clinical Trials Connect 2022 virtual summit on Wednesday 21 September at 13:25h BST | 14:25 CEST. Under the title…
Read more

ICPE2022

OXON AT ICPE Conference – 24-28 August2022

OXON’s real-world studies at the 38th International Conference on PharmacoEpidemiology, ICPE 2022.  Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community August 24-28, 2022 | Bella Center Copenhagen | Copenhagen, Denmark At OXON we are excited to be supporting ICPE 2022 as an exhibitor, presenting our capabilities and research during this in-person event for scientific and…
Read more

ICPE2021

OXON at ICPE21 All Access Virtual Conference on 23-25 August, 2021

OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.

""

OXON at ICPE20 All Access Virtual Conference on 16-17 Sep 2020

OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.